XML 54 R40.htm IDEA: XBRL DOCUMENT v3.19.2
Revenue - Major Products (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2017
Revenue from External Customer [Line Items]                      
Revenue, net $ 56,170 $ 56,012 $ 58,167 $ 55,609 $ 54,033 $ 50,562 $ 49,482 $ 49,127 $ 225,958 $ 203,204 $ 199,489
Concentration risk, percentage                 100.00% 100.00% 100.00%
Protandim® product line                      
Revenue from External Customer [Line Items]                      
Revenue, net                 $ 155,499 $ 133,923 $ 130,873
Concentration risk, percentage                 68.80% 65.90% 65.60%
TrueScience® product line                      
Revenue from External Customer [Line Items]                      
Revenue, net                 $ 20,881 $ 21,665 $ 24,440
Concentration risk, percentage                 9.20% 10.70% 12.30%
Product and Service, Other [Member]                      
Revenue from External Customer [Line Items]                      
Revenue, net                 $ 49,578 $ 47,616 $ 44,176
Concentration risk, percentage                 22.00% 23.40% 22.10%